250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical Startup Investors in Asia in July 2025

A list of 50 angel investors and VC (Venture Capital) funds that invest in Medical startups based in Asia. We rank investors based on the number of investments they made in Medical companies from Asia. We update this investor list every month.

Top 50 Medical Startup Investors in Asia in July 2025

Investor Medical Asia investments
HSG 34
BioVenture 31
Qiming Venture Partners 28
Med-Fine Capital 25
Legend Capital 23
Frees Fund 20
Mitsubishi UFJ Capital 18
Cowin Venture 18
Puhua Capital 17
Marathon Venture Partners 17
Shanghai Biomedical Industrial Equity Investment Fund 17
Prox Ventures 17
Matrix Partners China 16
Lilly Asia Ventures 15
ZSVC 15
Northern Light Venture Capital 15
Share Capital 15
Fast Track Initiative, Inc. 14
Legend Star 14
Jan Hammer 14
IDG Capital 14
SMBC Venture Capital 13
Dalton Venture 13
Highlight Capital 13
Cowin Capital 12
Sherpa Healthcare Partners 12
Goldport Capital 12
BioTrack Capital 12
CDH Investments 11
JAFCO 11
UTEC - The University of Tokyo Edge Capital Partners 11
ANRI 11
Keio Innovation Initiative 11
Nissay Capital 10
Cenova 10
Shenzhen Capital Group 10
Lenovo Capital and Incubator Group (LCIG) 10
Long Hill Capital 9
CD Capital 9
Kaitai Capital 9
Oriza Seed Capital (Oriza Yuandian) 9
Hillhouse Investment 9
Gaorong Capital 9
Huagai Capital 9
Taiyu Investment 9
UntroD Capital 9
Trustbridge Partners 9
Sunland Fund 9
Taiyu Investment 8
LYFE Capital 8
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
HSG VC Fund · Beijing, Beijing, China · 28 investments in the past 12 months
We help founders build enduring companies.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Series A, Series B, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • Manus AI — Manus is a general AI agent that turns your thoughts into actions. It excels at various tasks in work and life, getting everything done while you rest.
  • Noematrix — Noematrix is an embodied intelligence company that specializes in innovative general robotic intelligence solutions and services.
  • Xingkeyuan — Star Science is a high-performance lithium battery silicon-carbon negative electrode material research and development company. It has achieved small-scale mass manufacture of nano-silicon as well as the experimental development of high-efficiency silicon-carbon composite materials.
BioVenture VC Fund · Suzhou, Jiangsu, China · 8 investments in the past 12 months
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, Taiwan
Portfolio highlights
  • AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
  • Hengyu Medical — Hengyu Medical is a medical device firm focused on R&D and production of IVUS and optical coherence tomography, and catheter equipment.
  • Degron Therapeutics — Degron Therapeutics is a leading platform company in discovery of molecular glue degraders for cancer treatment.
Qiming Venture Partners VC Fund · Shanghai, Shanghai, China · 59 investments in the past 12 months
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series B, Series A, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
  • LongBio Pharma — LongBio Pharma is a biotech company that treats patients with an emphasis on complement and allergy diseases.
  • Tianchen Biotechnology — Tianchen Biotechnology is a biotech company that specializes in the research, design, development, and sales of ophthalmology-related medical products. It provides complete diagnostic and treatment solutions for ophthalmology.
Med-Fine Capital VC Fund · Shanghai, Shanghai, China · 4 investments in the past 12 months
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Seed, Series B
  • China, United States
Portfolio highlights
  • ZD Medical — ZD Medical develops phase variance optical coherence tomography that can detect macular degeneration and retinal microvascular proliferation caused by diabetes at the same time. It is a non-invasive, early-detection technology for diabetic retinopathy. ZD Medical's phase variance optical coherence tomography can detect both maculardegeneration and retinal microvascular proliferation caused by diabetes. ZD Medical brings together scientific and technological elites from both at home and abroad to pursue the development and manufacture of high-quality medical devices, and is dedicated to providing practical overall solutions for medical diagnosis and clinical treatment in order to benefit humanity's medical and health causes.
  • BV Laser — BV Laser is a manufacturer of medical beauty equipment.
  • Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.
Legend Capital VC Fund · Beijing, Beijing, China · 21 investments in the past 12 months
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series B, Series A, Series C
  • China, United States, South Korea
Portfolio highlights
  • Easy Flow — Easy-Flow is committed to efficiently creating a complete set of solutions in the field of peripheral interventional devices.
  • Force Inspiration — Force Inspiration is a start-up focusing on embodied intelligence technology. The company mainly engages in technology development, technical consulting, software development, basic artificial intelligence software development, information system integration services, intelligent robot research and development and sales, and industrial robotmanufacturing and sales.
  • Core Medical Technology — Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.
Frees Fund VC Fund · Beijing, Beijing, China · 15 investments in the past 12 months
By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.
Show more
Investment focus
  • Artificial Intelligence, Medical, Biotechnology
  • Series A, Seed, Angel
  • China, United States, Singapore
Portfolio highlights
  • Boin Biotechnology — Boin Biotechnology is a cutting-edge biopharmaceutical company. The company is dedicated to the development of gene therapy drugs, with a particular focus on advancing the next generation of gene therapy.
  • Interstellar Lightyear — Interstellar Lightyear Technology is a developer specializing in dexterous robotic hands, focusing on creating intelligent dexterous hands with advanced capabilities for precise manipulation.
  • Dingou Biopharmaceuticals — Dingou Biotechnology is a developer of allergen diagnosis and treatment products, mainly engaged in allergen-specific diagnosis and treatment business
Mitsubishi UFJ Capital VC Fund · Tokyo, Tokyo, Japan · 60 investments in the past 12 months
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Show more
Investment focus
  • Information Technology, Software, Health Care
  • Funding Round, Series A, Series B
  • Japan, United States, Singapore
Portfolio highlights
  • LiLz — LiLz is an IT technology network for businesses looking to use AI and IoT to offer new services and value.
  • EX-Fusion — EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation.
  • NABLA Mobility — Solving the complexities involved in the "Operation of Fleets" of Mobility and support its evolution and decarbonization
Cowin Venture VC Fund · Beijing, Beijing, China · 4 investments in the past 12 months
Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Angel, Series B
  • China, United States, Canada
Portfolio highlights
  • Fine Vision — Fine Vision is a company with R&D facilities in Nanjing and Wuhan that focuses on femtosecond laser application research in the fields of ocular surgery and biomaterial processing. The entire femtosecond laser corneal refractive surgery equipment, its first commercially available item, was developed by the university's WuhanOptoelectronics National Research Center under the Huazhong Technology Technology transition.
  • Yisheng Microna — Yisheng Microna is an ultrasonic transducer designer and developer, focusing on providing minimally invasive interventional ultrasonography catheters and transducers.
  • Guanchen Biotechnology — Guanchen Biotechnology is a developer of innovative cosmetic ingredients.
Puhua Capital VC Fund · Hangzhou, Zhejiang, China · 16 investments in the past 12 months
Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.
Show more
Investment focus
  • Health Care, Medical, Manufacturing
  • Series A, Series B, Seed
  • China, United Kingdom, United States
Portfolio highlights
  • Yifei Aviation — Yifei Aviation manufactures intelligent unmanned aerial vehicles (UAVs). Its primary business scope includes intelligent unmanned aerial vehicle manufacture, sales, and other services.
  • LuMing Robotics — LuMing Robotics is a developer of intelligent robots. LuMing Robotics focuses on the field of embodied intelligent robots, and its business covers intelligent robot R&D and sales, artificial intelligence algorithm development, etc.
  • Rongrui Technology — Rongrui Technology is an industrial enzyme developer, involved in industrial enzyme research and development; technical services, technology development, technology consulting, technology exchange, technology transfer, and technology promotion.
Marathon Venture Partners VC Fund · Shanghai, Shanghai, China · 2 investments in the past 12 months
Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Angel
  • China, United States, Hong Kong
Portfolio highlights
  • Natus — Nators specializes in precision motion positioning platforms, mechanical sensors, and nanoscience instruments, the company has developed precision positioning and sensing products for various applications, including optics, microscopy, and nano-level characterization and analysis. With a strong R&D capability and a complete production capacity,the company has become a partner of many domestic laboratories.
  • Kangai Medical — Kangai Medical specialises on clinical nutrition and rehabilitation
  • Femtosecond Technology — Femtosecond Technology is a developer of label-free biological imaging technology.Femtosecond Technology is a high-tech, "specialized and innovative" firm focusing on the application of femtosecond laser technology in clinical diagnosis and treatment, as well as biomedical industrialization.
Shanghai Biomedical Industrial Equity Investment Fund VC Fund · Huangpu, Shanghai, China · 7 investments in the past 12 months
Shanghai Biomedical Industrial Equity focuses on areas that are in line with the development strategy of the biomedical industry.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, Hong Kong
Portfolio highlights
  • Easy Flow — Easy-Flow is committed to efficiently creating a complete set of solutions in the field of peripheral interventional devices.
  • SaiDeDikang — SaiDeDikang is a company focusing on wound management solutions
  • NeuShen Therapeutics — NeuShen Therapeutics is a biotechnology company trailblazing the future treatment of neurological and psychiatric disorders.
Prox Ventures VC Fund · Shanghai, Shanghai, China
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more
Investment focus
  • Medical, Biotechnology, Health Care
  • Seed, Funding Round, Series A
  • China, United States, United Kingdom
Portfolio highlights
  • Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
  • Tuanxiang Pharmaceutical — Tuanxiang Pharmaceutical is an innovative drug research and development company that combines traditional new drug research and development with the use of the world's leading unique phase separation technology.
  • Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
Matrix Partners China VC Fund · Beijing, Beijing, China · 12 investments in the past 12 months
Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Series A, Series B, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • Sand.ai — Sand AI is an AI company that focuses on producing videos.
  • TOYA — TOYA specializes in the production of ultra-fine copper and copper alloy conductors.
  • LeXiang Intelligence — LeXiang Intelligence is a robotics company that specializes in the development of intelligent consumer-grade robots.
Lilly Asia Ventures VC Fund · Shanghai, Shanghai, China · 9 investments in the past 12 months
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • Fine Vision — Fine Vision is a company with R&D facilities in Nanjing and Wuhan that focuses on femtosecond laser application research in the fields of ocular surgery and biomaterial processing. The entire femtosecond laser corneal refractive surgery equipment, its first commercially available item, was developed by the university's WuhanOptoelectronics National Research Center under the Huazhong Technology Technology transition.
  • Stairway Medical — Stairway Medical is a developer of implantable brain-computer interface technology.
  • Timberlyne Therapeutics — Taking Best-in-Class Therapies to New Heights Our mission is to bring life-changing medicines to patients living with autoimmune diseases. About Us Timberlyne Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of transformational therapies for autoimmune diseases. We are leveraging the extensive drug development expertise
ZSVC VC Fund · Beijing, Beijing, China · 4 investments in the past 12 months
ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.
Show more
Investment focus
  • Manufacturing, Health Care, Medical
  • Series A, Seed, Series B
  • China, United States, India
Portfolio highlights
  • Micot — Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, abiological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like.
  • Zhisheng Bio — Zhisheng Bio specialzies in product research and development, and market transformation of biopharmaceutical products.
  • Prim Semiconductor — Prim Semiconductor specializes in ultra-high precision motion solutions, wafer transfer (EFEM), precision parts production, and comprehensive equipment research and development. The company focuses on providing integrated solutions across various sectors, including semiconductors, integrated circuit (IC) manufacturing, and new energy applications.
Northern Light Venture Capital VC Fund · Beijing, Beijing, China · 3 investments in the past 12 months
Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, South Korea
Portfolio highlights
  • VOC AI — VOC AI offers AI tools for ecommerce insights and customer service solutions.
  • AscentStream — AscentStream is a software development company that provides cloud messaging software and stream processing solutions.
  • Shengrun New Materials — Shengrun New Materials is an aerogel material and system solution service provider integrating advanced material process research and development, product application development, advanced production line design, and mature system solutions.
Share Capital VC Fund · Shenzhen, Guangdong, China
Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, Colombia
Portfolio highlights
  • Depp CNC — Depp CNC is a research and development manufacturer of CNC machine tools and core accessories.
  • Microview — Microview is a high-tech enterprise specializing in the research and development of high-precision complex process chip packaging equipment.
  • Jodell Robotics — Jodell develops intelligent robotic equipment designed to serve in automotive and logistics industries.
Fast Track Initiative, Inc. VC Fund · Hongo, Tokyo, Japan · 2 investments in the past 12 months
Fast Track Initiative is a venture capital firm with an exclusive focus on life sciences and healthcare services.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Seed, Funding Round
  • Japan, United States, United Kingdom
Portfolio highlights
  • Medii — Medii provides a physician sharing service for hospitals.
  • RegCell — RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer .
  • Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Legend Star VC Fund · Beijing, Beijing, China · 9 investments in the past 12 months
Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Seed, Angel
  • China, United States, France
Portfolio highlights
  • X-ORIGIN — X-ORIGIN is an intelligent robot developer focused on creating AI companion robots for a variety of applications. Its technical architecture emphasizes the integration of terminal control and massive language models, with the goal of providing a personalized interactive experience and creating more consumer-grade products based on self-developed AImodels.
  • Zhizai Wujie — Zhizai Wujie is a robotics company that specializes in research, development, and application of humanoid robots.
  • Direct Drive Technology — Direct Drive Technology provides direct drive solutions to replace the reduction gears in any machine. The company has a complete set of technologies for robot joints from sensors, drivers to motor bodies. Drive Tech uses a unique direct drive precise & powerful motion solution, thereby helping many other industries to boost different products.
Jan Hammer Angel · London, England, United Kingdom · 12 investments in the past 12 months
Jan joined Index in 2010, and is a London-based partner, focusing on fintech and information/data services across all stages of growth.He is one of Index Ventures’ leading fintech investors, working with the founders of Adyen, Credit Benchmark, Robinhood and TransferWise. In all, Index has backed more than two dozen fintech companies, withmore than $400 million. Jan has also led Index investments and is on the boards of Beamery, Collibra, SafetyCulture and Silverfin.Before he joined Index, Jan was at General Atlantic in London, where he worked on investments in Kaspersky Lab, Northgate Information Solutions and Torex Retail. He also worked in the M&A, TMT and Capital Markets divisions at Morgan Stanley. Jan is a graduate of Oxford University, and holds an MBA with Distinction from INSEAD.
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Series A, Series B, Seed
  • China, United States, United Kingdom
Portfolio highlights
  • MacroLux — MacroLux Medical Technology Co., Ltd.
  • Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
  • Xiwei Biotechnology — Xiwei Biotechnology is an ophthalmology implanted medical device developer that specializes in the unique product development of new bio-modified materials for ocular implantable medical devices and regenerative medicine.
IDG Capital VC Fund · Beijing, Beijing, China · 15 investments in the past 12 months
IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.
Show more
Investment focus
  • Software, Internet, E-Commerce
  • Series A, Series B, Series C
  • China, United States, India
Portfolio highlights
  • Sand.ai — Sand AI is an AI company that focuses on producing videos.
  • Kaia — Kaia is a public blockchain that utilizes Byzantine Fault Tolerance (BFT) for enhanced reliability and performance.
  • Wanhai Medical — Wanhai Medical is a prominent manufacturer specializing in the development and production of self-medication injection systems.
SMBC Venture Capital VC Fund · Tokyo, Tokyo, Japan · 45 investments in the past 12 months
Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.
Show more
Investment focus
  • Information Technology, Software, Health Care
  • Funding Round, Series A, Series B
  • Japan, United States, Singapore
Portfolio highlights
  • OPTEMO — OPTEMO develops and supplies sales technology that allows businesses and customers to connect through a website.
  • Skygate Technologies — Founded in 2020, Skygate Technologies is building a network to deliver a large volume of data from observation satellites around the Earth to the ground and integrating the network into the web architecture. “Make Space accessible on the Web” is its motto, and the ability to develop both hardware and software is its strength. More information aboutSkygate Technologies can be found at www.skygate-tech.com.
  • Phytolipid Technologies — Phytolipid Technologies specializes in the research and production of lipids in plants and algae and is an expert in lipid analysis.
Dalton Venture VC Fund · Shanghai, Shanghai, China · 8 investments in the past 12 months
Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Seed, Series A, Series B
  • India, China, Canada
Portfolio highlights
  • Astribot — Astribot is a developer of consumer humanoid robots and integrated bionic robots.
  • Yuantian Bio — Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.
  • Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
Highlight Capital VC Fund · Nanjin, Jiangsu, China · 21 investments in the past 12 months
Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, Portugal
Portfolio highlights
  • ENGINEAI — ENGINEAI is committed to advancing the commercialization of humanoid robot technology worldwide.
  • Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
  • Shenandoah Therapeutics — Shenandoah Therapeutics is a biotechnology company.
Cowin Capital VC Fund · Shenzhen, Guangdong, China · 32 investments in the past 12 months
Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.
Show more
Investment focus
  • Manufacturing, Health Care, Biotechnology
  • Series A, Series B, Seed
  • China, Hong Kong, United States
Portfolio highlights
  • Tsinghua Huahe — Tsinghua Huahe is a medical devices company that provides research and development of modified PEEK materials.
  • Hangrun Aviation — Hangrun Aviation specializes in aviation engine inspection and maintenance, including engine disassembly, sales, exchange, leasing, maintenance management, and other services.
  • Zhongke Chuncui Technology — Zhongke Chuncui Technology is ahigh-tech enterprise focusing on the efficient separation and extraction of new energy strategic metals.
Sherpa Healthcare Partners VC Fund · Beijing, Beijing, China · 8 investments in the past 12 months
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • China, United States, Kenya
Portfolio highlights
  • AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
  • PAQ Therapeutics — PAQ Therapeutics is developing KRAS degraders for deadly cancers without good treatment options.
  • Archimedes Vascular — Archimedes Vascular operates as a medical device company, that treat patients with severe hypertension.
Goldport Capital VC Fund · Shenzhen, Guangdong, China · 5 investments in the past 12 months
Goldport Capital is a Shenzhen-based asset management company.
Show more
Investment focus
  • Manufacturing, Medical, Semiconductor
  • Series A, Seed, Series B
  • China
Portfolio highlights
  • Yisite Biotech — Yisite Biotech is a technology-driven enterprise that concentrates on advancements in the field of synthetic biology.
  • Chaoguang Micro — Chaoguang Micro specializes in the innovative development of optical products for medical and industrial purposes.
  • Teyan Semiconductor — Taiyan Semiconductor is a semiconductor process and equipment service provider in the field of advanced packaging. It provides customers with advanced packaging production lines such as SiP, Fanout, Chiplet, 3D, etc. Laser (laser) + Plasma (plasma) + Sputter (coating) complete composite process and Process application equipment.
BioTrack Capital VC Fund · Shanghai, Shanghai, China · 7 investments in the past 12 months
BioTrack Capital is a China-based investment firm.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Seed
  • China, United States, Singapore
Portfolio highlights
  • Spurious — Sipurui is a pharmaceutical company specializing in the development of small molecule anti-tumor drugs, with a particular emphasis on iterative innovation to enhance the efficacy and selectivity of cancer therapies.
  • Cavan Auto — Cavan Auto specializes in the production of electric vehicles and hydrogen fuel cell-powered new energy.
  • Sirius Therapeutics — Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.
CDH Investments VC Fund · Kowloon City, Kowloon, Hong Kong · 20 investments in the past 12 months
CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.
Show more
Investment focus
  • Manufacturing, Biotechnology, Health Care
  • Series A, Series B, Series C
  • China, United States, Canada
Portfolio highlights
  • Robot Era — Robot era is an emerging technology business creates embodied intelligence and generic humanoid robot technologies and products. Xingdong Era is committed to the development of universal humanoid robots that can adapt to a wide range of fields, multiple scenarios, and high intelligence, striving to realize the beautiful vision of intelligent robotsentering thousands of households and integrating into the lights of thousands of homes.
  • Tiejin Technology — Tiejin Technology is a humanoid robotics company that provides research and development related to micro and ultra-micro bearings.
  • Rongrui Technology — Rongrui Technology is an industrial enzyme developer, involved in industrial enzyme research and development; technical services, technology development, technology consulting, technology exchange, technology transfer, and technology promotion.
JAFCO VC Fund · Tokyo, Tokyo, Japan · 21 investments in the past 12 months
Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to thecreations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing.
Show more
Investment focus
  • Information Technology, Software, Artificial Intelligence
  • Series A, Funding Round, Series B
  • Japan, United States, Israel
Portfolio highlights
  • ADiXi — Adixi is a tech-driven business that supports the idea that people and technology may work together. It strives to open doors by utilizing cutting-edge technology, such as artificial intelligence, to promote long-term, sustainable corporate and societal progress.
  • OPERe — OPERe is an IT company that specializes in the development of semi autonomous hospitalization guidance solutions.
  • Skygate Technologies — Founded in 2020, Skygate Technologies is building a network to deliver a large volume of data from observation satellites around the Earth to the ground and integrating the network into the web architecture. “Make Space accessible on the Web” is its motto, and the ability to develop both hardware and software is its strength. More information aboutSkygate Technologies can be found at www.skygate-tech.com.
UTEC - The University of Tokyo Edge Capital Partners VC Fund · Tokyo, Tokyo, Japan · 13 investments in the past 12 months
UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Funding Round
  • Japan, United States, Singapore
Portfolio highlights
  • Peach Cars — Buy or sell your car in Nairobi-Kenya with ease. Browse a wide range of vehicles, connect with trusted sellers, and find the perfect car today. Simple, fast, and secure transactions.
  • Piece — Piece is a digital real estate platform offering the easiest and most transparent way to participate in income-producing real estate in Europe. Our mission is to make real estate ownership inclusive and more accessible.
  • Forest — Forest Co., Ltd. operates as an e-commerce aggregator, seeks to identify sustainable, high-quality products and brands that embrace the spirit of Japan and help them grow and enter the global market by using the power of technology.
ANRI VC Fund · Tokyo, Tokyo, Japan · 24 investments in the past 12 months
ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Funding Round, Series A
  • Japan, United States, India
Portfolio highlights
  • AiCAN — AiCAN provides system planning and development, data analysis, IT, and consulting services related to child welfare.
  • Asusola — Asusola engaged in the renewable energy power generation business
  • Linea Innovations — Linea Innovations is an energy production company that develops commercial fusion reactors with advanced fuel technology.
Keio Innovation Initiative VC Fund · Tokyo, Tokyo, Japan · 11 investments in the past 12 months
Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Funding Round, Series A, Seed
  • Japan
Portfolio highlights
  • Linqmed — Linqmed is a pharmaceutical company that specializes in the research and development of radiopharmaceuticals for cancer treatment.
  • Aeterlink — Aeterlink is a wireless device maker and developer. They applied their technology to fields such as FA, robots, smart houses, and medicine and developed practical level technologies such as elemental technology that can wirelessly supply power.
  • Linea Innovations — Linea Innovations is an energy production company that develops commercial fusion reactors with advanced fuel technology.
Nissay Capital VC Fund · Tokyo, Tokyo, Japan · 25 investments in the past 12 months
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
Show more
Investment focus
  • Health Care, Internet, Information Technology
  • Funding Round, Seed, Series A
  • Japan, United States, Ethiopia
Portfolio highlights
  • Blackbox — Blackbox is an entertainment firm that is involved in businesses, including VTuber production, media mix, and live music events.
  • Knowhere — Knowhere is a company that applies high-performance AI to sports.
  • Linea Innovations — Linea Innovations is an energy production company that develops commercial fusion reactors with advanced fuel technology.
Cenova VC Fund · Shanghai, Shanghai, China · 3 investments in the past 12 months
Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series B, Series A, Series C
  • China, Singapore, United States
Portfolio highlights
  • Weimai — Weimai is a developer of a health application platform intended to provide medical and health services. The company's health application platform offers an Internet-based appointment, distribution, maternal and child disease management, grading diagnosis and treatment as well as remote diagnosis, and medical records management, providing userswith a family doctor application in every home.
  • Haofeng Medtech — Haofeng Medtech is a CDMO service provider of interventional medical devices.
  • Agile Medical — Agile Medical, a surgical robot company, focuses on research, development, and industrialization of intelligent surgical products. Agile Medical's technology innovation platform covers mechanics, electronics, optics, computing, and software.
Shenzhen Capital Group VC Fund · Shenzhen, Guangdong, China · 48 investments in the past 12 months
Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by the Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation, and emerging industries developing. SCGC has registered capital of 5.42 billion RMB,and a total AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based on the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.
Show more
Investment focus
  • Manufacturing, Health Care, Information Technology
  • Series A, Series B, Series C
  • China, United States, Japan
Portfolio highlights
  • Hurrichip — Hurrichip manufactures gallium nitride semiconductor lasers that is used during semiconductor testing.
  • ENCOS — ENCOS is a developer of high-performance robot integrated joint modules. The company focuses on matters of embodied intelligence, with robot reduction motors as its main business.
  • Shouxing Technology — AheadForm is pioneering the development of realistic humanoid robots designed to revolutionize human-robot interaction. Our current focus is on creating sophisticated humanoid robot heads that can express emotions, perceive their environment, and interact seamlessly with humans. By combining cutting-edge AI and advanced robotics, we aim to bring life to machines and transform the way humans engage with technology.
Lenovo Capital and Incubator Group (LCIG) VC Fund · Beijing, Beijing, China · 21 investments in the past 12 months
Lenovo Capital and Incubator Group is an accelerator and venture capital firm.
Show more
Investment focus
  • Manufacturing, Artificial Intelligence, Software
  • Series A, Series B, Seed
  • China, Hong Kong, United States
Portfolio highlights
  • DexForce — DexForce offers an AI-enabled robot with integrated 3D vision cameras, and software and hardware solutions for manufacturing robots.
  • Lanxin Computing — Lanxin Computing is a high-performance chip design company that focuses on the research and development of CPUs with RISC-V ecosystems.
  • Orbital Chenguang — Orbital Chenguang is a aerospace company that helps to launch and deploy deploy computing satellites into Earth's dawn and dusk orbits to construct a space data center committed to offering space-based computing services.
Long Hill Capital VC Fund · Shanghai, Shanghai, China
Long Hill Capital is a next generation thesis-driven venture capital firm. We invest in technology-enabled healthcare and consumer services companies which seek to massively improve health and quality of life for every Chinese.Since 2005 the founding team of Long Hill Capital have led the China investing practice for New Enterprise Associates(NEA), a global investment firm with over $17 billion in committed capital. They are joined by an experienced team of investment and operations professionals from such firms as Matrix Partners China and Morningside VC. Together the Long Hill Capital team have over 30 years of China venture capital experience and over 15 years of senior operating experience at some of China’s most successful technology and healthcare companies including Alibaba, Huawei and Ping’an Good Doctor.Over the course of their venture capital careers, the Long Hill Capital team have invested in such industry leading companies as CITIC Pharmaceutical, WeDoctor, Hygeia Medical Services, GST Clinics, LineKong, LianLian Pay, Ele.Me, TheBeastShop and more.
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Series A, Series B, Angel
  • China, United States
Portfolio highlights
  • Filan Air — Filan Air develops technology for improving air quality, such as air treatment for medical laboratories.
  • Aibo Medical Robot — Aibo Medical Robot was established in Shenzhen in June 2020, focusing on the vascular interventional surgery robot market. It is reported that behind this "new" company is the accumulation of years of scientific research and technology - that is , the nearly 30 years of research and development accumulation of the founding team.
  • Oushisheng Technology — Oushisheng Technology is a national high-tech company that provides complete solutions for micro-reaction flow chemistry to people all over the world.
CD Capital VC Fund · Shanghai, Shanghai, China
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Series B, Seed
  • China, United States
Portfolio highlights
  • Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
  • Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
  • Qihe Biotech — Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.
Kaitai Capital VC Fund · Hangzhou, Zhejiang, China
KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series A, Angel, Series B
  • China, United States
Portfolio highlights
  • Xinyue — Yuejing Network Technology Co., Ltd. is a digital video assistant platform that cuts in the communication and review links in the video production stream, helping to achieve multi-platform preview of video demos in video production and convenient review comments and video storage. sort out. With the subsequent connection of external hardware, theuser can realize the real-time synchronization of the video data captured in the camera to the new cloud server, and later can synchronize production and storage sharing through the new reading.
  • Sheng Sheng Biology — Sheng Sheng Biology is a biotechnology company that provides medical research and experimental development services.
  • TechnoDerma Medicines — TechnoDerma Medicines focuses on the research and development of innovative skin drugs for external use.
Oriza Seed Capital (Oriza Yuandian) VC Fund · Suzhou, Jiangsu, China · 18 investments in the past 12 months
Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.
Show more
Investment focus
  • Manufacturing, Health Care, Biotechnology
  • Series A, Seed, Angel
  • China, United States, Singapore
Portfolio highlights
  • Xingkeyuan — Star Science is a high-performance lithium battery silicon-carbon negative electrode material research and development company. It has achieved small-scale mass manufacture of nano-silicon as well as the experimental development of high-efficiency silicon-carbon composite materials.
  • Scanner Optics Co.,Ltd — Scanner Optics is professional in galvanometer scanners, controllers, software, optics, encoders and customized galvanometer systems. Our galvo scanner products have been applied in many industries: laser marking, laser cutting, laser welding, laser scanning, 3D printing and so on. Contact Scanner Optics now!
  • Xili Optoelectronics — Xili Optoelectronics is a pioneering company focused on the development of advanced, future-oriented optical engine system integrated chips (OE-SICs) that deliver high bandwidth and low energy consumption.
Hillhouse Investment VC Fund · Changyang, Beijing, China · 3 investments in the past 12 months
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Series B, Series A, Series C
  • China, United States, Singapore
Portfolio highlights
  • dinii — Dinii is a mobile order platform for take-out shops.
  • Ascentium — At Ascentium, we believe in the power of partnership to realise unlimited growth potential.
  • Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
Gaorong Capital VC Fund · Wangjing, Beijing, China · 14 investments in the past 12 months
Gaorong Capital is a venture capital firm that focuses on early and growth stage investments in TMT, including AI and frontier technologies.
Show more
Investment focus
  • Information Technology, Artificial Intelligence, E-Commerce
  • Series A, Series B, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • Flexiv — Flexiv is a deep-tech company that is committed to developing and manufacturing general-purpose adaptive robots that redefine intelligent automation. Combining advanced robotics and artificial intelligence with human-centered design, Flexiv's robots empower businesses to flexibly automate complex tasks with intuitive and easy-to-use interfaces.
  • Pulnovo Medical — Pulnovo Medical integrates development, production and services. Our core products including use pf radiofrequency ablation technology to treat pulmonary hypertension. The high-frequency ablation equipment and intravascular catheters developed by the company are pioneer inventions with global invention patents.
  • HashKey — Established in 2018, HashKey Group is a leading end-to-end digital asset financial services group in Asia that upholds the principle of "compliance first"
Huagai Capital VC Fund · Beijing, Beijing, China · 4 investments in the past 12 months
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Seed
  • China, United States, Germany
Portfolio highlights
  • Amazinc — Amazinc is a zinc battery R&D and production company that specializes in zinc battery development and manufacture.Amazinc offering a systematic design of leading zinc-based battery solutions, including energy storage mechanisms, battery materials, and structural design.
  • ViGeneron — ViGeneron is dedicated to developing innovative gene therapies to treat ophthalmic diseases with high unmet medical need, as well as partnering with leading biopharmaceutical players in other disease areas. The company’s pipeline is built on two proprietary adeno-associated virus (AAV) technology platforms. The first, vgAAV gene therapy vectorplatform, allows superior transduction efficiency and intravitreal, less invasive treatment administration. The second, REVeRT vector platform, targets diseases caused by mutations in large genes. Privately-owned ViGeneron was founded in 2017 by a seasoned team with in-depth experience in AAV vector technology and clinical ophthalmic gene therapy programs and is located in Munich, Germany.
  • Index Technology — Index Technology is a company that specializes in applying artificial intelligence technology to electronic design and production. Index Technology uses generative AI technology to optimize the traditional R&D process for electrical devices, and it offers automated generation services ranging from product requirements to PCBA manufacturingdesigns and supporting embedded programs.
Taiyu Investment VC Fund · 4 investments in the past 12 months
Taiyu Investment is an investment firm.
Show more
Investment focus
  • Medical, Medical Device, Biotechnology
  • Series A, Angel, Seed
  • China
Portfolio highlights
  • NeuroPlus — NeuroPlus is a developer of bioelectric sensing technologies, with an emphasis on new applications such as precise EEG measurement, smart wearables, and mobile medical care.
  • Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.
  • Bochuang Biotechnology — Bochuang Biotechnology is a cutting-edge medical repair product developer that specializes in the controllable electrochemical assembly of biomacromolecules. Bochuang Biotechnology is creating a line of high-end biological tissue functional membranes and derived medical device solutions.
UntroD Capital VC Fund · Sumida, Tokyo, Japan · 5 investments in the past 12 months
UntroD Capital is an R&D-based innovative technology that specializes in social implementation.
Show more
Investment focus
  • Manufacturing, Biotechnology, Robotics
  • Funding Round, Seed, Series A
  • Japan, Singapore, India
Portfolio highlights
  • Alternō — Alternō was founded with a vision to create Asia's first low-cost thermal energy storage solution for renewable energy, to be deployed widely across the region by 2050. Alternō received early stage funding from Antler VC in Jan 2023 to kick off the research & development.
  • Q5D Technology — Additive manufacturing with conductors. Eliminate traditional wiring, saving space and weight. Unique 5-axis robots add power and data functions to products. Simplify supply chains and manufacturing. Transform productivity with our hardware, software, and support.
  • Optieum Biotechnologies — Optieum Biotechnologies Inc. is a pre-clinical stage biotechnology company committed to developing innovative scFv antibody-based therapies for the treatment of patients with cancers. Their proprietary platform technology, Eumbody System™, enables to develop and detect a scFv-based product candidates that specifically bind to, and modulate tooptimize the immune-cell function for oncology targets.We are committed to helping patients with severe diseases by bringing life-changing therapies to the patients in need.
Trustbridge Partners VC Fund · Boston, Massachusetts, United States
Trustbridge Partners is a mission-driven growth equity firm founded in 2006 with approximately $8 billion under management.
Show more
Investment focus
  • Health Care, Education, Medical
  • Series A, Series B, Series C
  • China, United States, United Kingdom
Portfolio highlights
  • Cherre — Connect all your real estate data and make it available to the entire organization for better investment, management, and underwriting decisions.
  • Hystar — Hystar develops polymer electrolyte membrane electrolyzers designed for large-scale green hydrogen production. Founded in 2020, Hystar's technology uses a unique cell design and process architecture that provides the ability to reduce electricity consumption and increase hydrogen output, enabling professionals to tackle various criticalenergy challenges and having the potential to reduce greenhouse gas emissions.
  • Hope Medicine — Hope Medicine is committed to researching, developing and commercializing the first innovative drugs aimed at improving the quality of life for a wide range of popular male and female diseases.
Sunland Fund VC Fund · Shanghai, Shanghai, China
Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Series A, Series B, Seed
  • China
Portfolio highlights
  • Better Medtech — Better Medtech is a provider of innovative solutions for urinary and pelvic floor health. Its primary business is the research and development, production, sales, and related services of specialized medical devices, with a focus on creating comprehensive and precise revolutionary products in markets such as benign prostatic hyperplasia, urinaryincontinence, stones, and novel tumour therapies.
  • Juhe Biotechnology — Juhe Biotechnology is a company that creates early detection tools for gynecological malignancies.
  • Medtech Technology — Medtech Technology is a firm that develops innovative ophthalmic medical devices.It has developed its own artificial lens production and research technology platform, as well as a technological barrier to high-end artificial lens manufacture.
Taiyu Investment VC Fund · Beijing, Beijing, China
Taiyu Investment is an investment firm.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Series A, Seed, Angel
  • China
Portfolio highlights
  • Immorna — Immorna specializes in the production of RNA-based therapeutics.
  • ChomiX Biotech — ChomiX Biotech will always manage the company's development with a realistic, disciplined, and excellence-driven scientific research mindset. In addition, the company will use cutting-edge technology to solve problems for clients and generate revenue. We can only see the stars if we stay grounded. ChomiX will continue to research and developits own core technology in order to continually maintain its top rank on the track and steer the development of the industry.
  • Weixin Medical — Weixin Medical is an innovative medical device platform for women's health.
LYFE Capital VC Fund · Shanghai, Shanghai, China · 4 investments in the past 12 months
LYFE Capital is a pure play healthcare focused investment firm. We believe that “Healthcare has no boundaries”, and that every new choice we made has the potential to advance healthcare and solve the unmet needs for everyone. LYFE Capital operates 5 global offices including our US headquarters in Menlo Park, California, our Asia headquarters inSingapore, as well as locations in Seoul, Tokyo and Shanghai. We leverage our expertise and global resources to invest in and create value for healthcare companies across the globe. LYFE Capital’s investments span medical devices, therapeutics, diagnostics, and emerging sectors across North America and Asia.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • China, United States, France
Portfolio highlights
  • CytoTronics — Visualize live cell function at scale for cell biology discovery with Pixel systems. Monitor cell viability, morphology, electrophysiology, metabolism and more.
  • Verdiva Bio — Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options.
  • Precision BioSciences — Precision BioSciences is a biotechnology company dedicated to improving lives through its next-generation gene editing technology, ARCUS.Precision BioSciences’ mission is to translate the world’s most powerful genome editing technology into greatly needed products throughout the life sciences. Precision’s proprietary ARCUS genome editingtechnology enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome.
Investors by industry
Investors by country
Investors in Asia by industry